Indivior avoids multi-state antitrust trial with $100m payout

06-06-2023

Muireann Bolger

Indivior avoids multi-state antitrust trial with $100m payout

IgorGolovniov / Shutterstock.com

Case involved the alleged monopolisation of an opioid addiction treatment | More than 40 attorneys general had filed complaints against the pharma company.


Indivior, company, drug, addiction, monopolisation, attorneys general, Suboxone, Mark, Crossley, ANDA, multi-state

More on this story

Indivior parts with $30m in Suboxone dispute
22-08-2023

LSIPR